ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $44,000 | +2.3% | 30,067 | -0.0% | 0.00% | 0.0% |
| Q4 2016 | $43,000 | -6.5% | 30,079 | +15.6% | 0.00% | -33.3% |
| Q3 2016 | $46,000 | +7.0% | 26,026 | +0.5% | 0.00% | +50.0% |
| Q2 2016 | $43,000 | -14.0% | 25,902 | +1.4% | 0.00% | -60.0% |
| Q1 2016 | $50,000 | +13.6% | 25,533 | +9.7% | 0.01% | 0.0% |
| Q4 2015 | $44,000 | -8.3% | 23,274 | -7.9% | 0.01% | 0.0% |
| Q3 2015 | $48,000 | -58.6% | 25,271 | +0.9% | 0.01% | -54.5% |
| Q2 2015 | $116,000 | +9.4% | 25,042 | +3.1% | 0.01% | -15.4% |
| Q1 2015 | $106,000 | +43.2% | 24,295 | +13.2% | 0.01% | +8.3% |
| Q4 2014 | $74,000 | -17.8% | 21,454 | +0.1% | 0.01% | -7.7% |
| Q3 2014 | $90,000 | -28.6% | 21,425 | -0.0% | 0.01% | -31.6% |
| Q2 2014 | $126,000 | 0.0% | 21,432 | +6.8% | 0.02% | -13.6% |
| Q1 2014 | $126,000 | +5.9% | 20,069 | -1.0% | 0.02% | +10.0% |
| Q4 2013 | $119,000 | – | 20,262 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |